U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939816) titled 'Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)' on April 07.
Brief Summary: This study is designed to establish the effect of 2 doses of vonafexor on the kidney. This will be investigated in subjects with mild or moderate reduced estimated glomerular filtration rate (eGFR) and suspected MASH. In addition, the non-invasive multiparametric magnetic resonance imaging assessment of functional and structural changes in the kidney and in the liver will be investigated.
Study Start Date: July 01, 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease ...